BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15937818)

  • 21. GLUT1 glucose transporter: a highly sensitive marker of malignancy in body cavity effusions.
    Burstein DE; Reder I; Weiser K; Tong T; Pritsker A; Haber RS
    Mod Pathol; 1998 Apr; 11(4):392-6. PubMed ID: 9578091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of GLUT1 in primary renal tumors: morphologic and biologic implications.
    Ozcan A; Shen SS; Zhai QJ; Truong LD
    Am J Clin Pathol; 2007 Aug; 128(2):245-54. PubMed ID: 17638658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose transporter type 1 expression are associated with poor prognosis in patients with salivary gland tumors.
    Mori Y; Tsukinoki K; Yasuda M; Miyazawa M; Kaneko A; Watanabe Y
    Oral Oncol; 2007 Jul; 43(6):563-9. PubMed ID: 17071132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of prox1, lymphatic endothelial nuclear transcription factor, in Kaposiform hemangioendothelioma and tufted angioma.
    Le Huu AR; Jokinen CH; Rubin BP; Mihm MC; Weiss SW; North PE; Dadras SS
    Am J Surg Pathol; 2010 Nov; 34(11):1563-73. PubMed ID: 20975337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targetoid hemosiderotic hemangiomas (hobnail hemangiomas) are vascular lymphatic malformations: a study of 12 pediatric cases.
    Al Dhaybi R; Lam C; Hatami A; Powell J; McCuaig C; Kokta V
    J Am Acad Dermatol; 2012 Jan; 66(1):116-20. PubMed ID: 21798621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Verrucous hemangioma revisited.
    Tennant LB; Mulliken JB; Perez-Atayde AR; Kozakewich HP
    Pediatr Dermatol; 2006; 23(3):208-15. PubMed ID: 16780464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GLUT-1 in oral benign vascular lesions.
    Johann AC; Salla JT; Gomez RS; de Aguiar MC; Gontijo B; Mesquita RA
    Oral Dis; 2007 Jan; 13(1):51-5. PubMed ID: 17241430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphological and immunohistochemical features of malignant vascular tumors with special emphasis on GLUT1, and FKBP12 expressions.
    Kösemehmetoğlu K; Gedikoğlu G; Ruacan S
    Turk Patoloji Derg; 2011 Jan; 27(1):57-67. PubMed ID: 21469428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Congenital haemangiomas and other rare infantile vascular tumours].
    Enjolras O; Picard A; Soupre V
    Ann Chir Plast Esthet; 2006; 51(4-5):339-46. PubMed ID: 16997442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mesenchymal tumors of the liver: their frequency and histopathological diagnostic problems in surgical investigations].
    Flemming P; Lang H; Georgii A
    Verh Dtsch Ges Pathol; 1995; 79():116-9. PubMed ID: 8600674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between the glucose transporter type 1 expression and F-fluorodeoxyglucose uptake in esophageal squamous cell carcinoma.
    Hiyoshi Y; Watanabe M; Imamura Y; Nagai Y; Baba Y; Yoshida N; Toyama E; Hayashi N; Baba H
    Oncology; 2009; 76(4):286-92. PubMed ID: 19262068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant vascular tumors of liver in neonates.
    Nazir Z; Pervez S
    J Pediatr Surg; 2006 Jan; 41(1):e49-51. PubMed ID: 16410090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathological reporting of paediatric cutaneous vascular anomalies in relation to proposed multidisciplinary classification system.
    Al-Adnani M; Williams S; Rampling D; Ashworth M; Malone M; Sebire NJ
    J Clin Pathol; 2006 Dec; 59(12):1278-82. PubMed ID: 16751300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diversity of glial cell components in pilocytic astrocytoma.
    Tanaka Y; Sasaki A; Ishiuchi S; Nakazato Y
    Neuropathology; 2008 Aug; 28(4):399-407. PubMed ID: 18312545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial cells of intramuscular (infantile) hemangioma express glut1.
    Drut R; Altamirano E
    Int J Surg Pathol; 2007 Apr; 15(2):166-8. PubMed ID: 17478771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic implications of glucose transporter protein-1 (glut-1) overexpression in bone and soft-tissue sarcomas.
    Endo M; Tateishi U; Seki K; Yamaguchi U; Nakatani F; Kawai A; Chuman H; Beppu Y
    Jpn J Clin Oncol; 2007 Dec; 37(12):955-60. PubMed ID: 18211986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wilms tumor 1 expression in vascular neoplasms and vascular malformations.
    Trindade F; Tellechea O; Torrelo A; Requena L; Colmenero I
    Am J Dermatopathol; 2011 Aug; 33(6):569-72. PubMed ID: 21697701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.